Koers Rayont, Inc. Other OTC
Aandelen
RAYT
US75508M1009
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 2,97 mln. 2,75 mln. | Omzet 2022 | 2,84 mln. 2,63 mln. | Marktkapitalisatie | 45,69 mln. 42,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | 47,8 x |
Nettoschuld 2021 | 2,4 mln. 2,23 mln. | Nettoschuld 2022 | 7,78 mln. 7,21 mln. | EV/omzet 2022 | 18,8 x |
K/w-verhouding 2021 |
293
x | K/w-verhouding 2022 |
186
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 48,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 31-03-20 | |
Ilenna Copley
COO | Chief Operating Officer | - | 16-05-22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 21-04-22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25-03-21 |
Chief Executive Officer | 48 | 31-03-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+46,45% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |